ORIC Pharmaceuticals, Inc. (ORIC) Stock

Healthcare · Biotechnology · Member of Other US Stocks

ORIC Pharmaceuticals, Inc. (ORIC) closed at USD 11.59 on 2026-10-14, a change of -13.7 % over the past year, with a market capitalization of USD 1.32B.

ORIC Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

ORIC Pharmaceuticals, Inc. key figures

Previous close

USD 11.59 (2026-10-14)

1-year change

-13.7 %

Market cap

USD 1.32B

Enterprise value

USD 1.06B

P/E ratio (trailing)

-9.46

P/E ratio (forward)

-7.63

EPS (trailing)

-1.35

EPS (forward)

-1.67

PEG ratio

n/a

Price to book

3.47

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

11.16

Employees

111

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates include enozertinib formerly known as ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and rinzimetostat formerly known as ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. It has a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for ORIC Pharmaceuticals, Inc. and compare it with other stocks.